Detecting infection. Identifying resistance. Faster.
A PCR-based diagnostic in development to detect surgical site infections across critical specialities and identify antibiotic resistance, so the right treatment reaches the right patient at the right time.
Discuss Collaboration
Surgical site infections cost lives, billions, and trust.
Traditional culture methods are slow, often inaccurate, and miss critical antibiotic resistance information. The result: delayed treatment, prolonged admissions, revisional surgeries, and patient harm. The system needs faster, more decisive answers.
Delayed treatment increases morbidity risk and admission length.
Per case, with significant flow-on effects to hospital revenue and capacity.
Most are detected post-discharge, complicating accurate measurement.
A baseline rate that compounds across specialities and patient volumes.
PCR diagnostics built for the realities of surgical care.
We are developing an advanced PCR-based diagnostic platform designed to identify surgical site infections across specific specialities and detect antibiotic resistance markers in the same workflow. Our goal: faster, more decisive results that de-risk surgery, protect patients, and reduce the operational and financial pressure on hospitals.
Rapid Pathogen Detection
PCR-based identification of surgical site infections across targeted specialities, drastically faster than traditional culture.
Antibiotic Resistance Profiling
Detects resistance markers in the same test, so clinicians can prescribe the right antibiotic from the first decision.
Built for Global Deployment
Engineered for compatibility with multiple PCR platforms, enabling broad scalability across diverse healthcare environments.
Co-Designed with Clinicians
Built in collaboration with surgeons, infectious disease specialists, and laboratory leaders to fit real surgical workflows.
We listen to the market, identify the gaps, and build solutions where the system is failing patients.
A multi-disciplinary team. International partnerships.
Bringing a diagnostic from concept to clinical adoption takes more than science. It takes operators, clinicians, regulatory experts, and partners who understand the systems we're working in.
Multi-Disciplinary Expertise
Our team brings together molecular diagnostics, surgical specialty insight, regulatory experience, and commercial execution. Every workstream is led by people who have shipped diagnostics into clinical practice before.
International Partnerships
We are actively collaborating with healthcare professionals, researchers, laboratories, and investors across multiple regions to validate, scale, and deploy our diagnostic. If you operate outside these regions, we still want to hear from you.
Want to learn more? Let's talk under NDA.
We can share detailed technical, clinical, and commercial information about this diagnostic under a mutual non-disclosure agreement with serious collaboration partners. As we progress and are cleared to publicly disclose, updates will appear here and on our social channels.
Let's build the future of healthcare, together.
If you are a clinician, researcher, laboratory, hospital network, or investor interested in collaborating on next-generation surgical infection diagnostics, we'd like to hear from you.
Start a Conversation Or email us at [email protected]